AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Streetinsider

Published November 4, 2026 · Updated November 5, 2026

Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Ships PEX010 to ... - StreetInsider

Read the full story at Streetinsider

Psychedelic Therapy Trial. November 3, 2026 8:03 AM. Filament has shipped PEX010 to the Keck ... release/322278. Categories. Newsfile Press Releases .

Post on X

Share this story

Surfaced by this Google Alert

Psychedelic press release